ClinConnect ClinConnect Logo
Search / Trial NCT04919265

Mother-Infant Cohort Study in Malaysia and China

Launched by UNIVERSITI PUTRA MALAYSIA · Jun 7, 2021

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

Gut Microbiota Mother Infant Cohort Study Breastmilk

ClinConnect Summary

The Mother-Infant Cohort Study is a research project taking place in Malaysia and China. This study aims to understand how the bacteria found in breast milk from mothers in these two countries can affect the health and development of their infants. Researchers want to see if these differences in breast milk can influence things like a baby's mood, tummy troubles, skin issues like eczema, and even asthma symptoms.

To participate in this study, women need to be pregnant and between the ages of 18 and 45. They should be visiting specific clinics for their prenatal check-ups and plan to continue attending check-ups after the baby is born for at least a year. Unfortunately, women who have certain health issues or are expecting more than one baby, among other criteria, are not eligible. Participants can expect to provide breast milk samples and answer questions about their health and their baby’s development over time, helping researchers learn more about these important connections.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Pregnant women aged between 18 and 45 years old
  • Pregnant women who attend the antenatal check-up at the selected clinics/hospitals
  • Pregnant women with the gestational age of less than 12 weeks
  • Pregnant women who plan to attend post-natal check-ups for at least one year at the same clinic/hospital
  • Exclusion Criteria:
  • Pregnant women who are diagnosed with immune deficiency
  • Pregnant women who have a multiple pregnancy and preterm delivery (\<37 weeks)
  • Pregnant women who plan to move out of the study area in the next one year
  • Pregnant women with fetal/newborn with congenital abnormalities

About Universiti Putra Malaysia

Universiti Putra Malaysia (UPM) is a prestigious research university located in Malaysia, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, UPM leverages its extensive academic resources and expertise to conduct rigorous research aimed at improving patient outcomes and contributing to the global body of medical knowledge. The university fosters collaboration among multidisciplinary teams, ensuring that its clinical trials adhere to the highest ethical and regulatory standards while addressing critical health challenges. Through its initiatives, UPM plays a vital role in translating scientific findings into practical applications that benefit society.

Locations

Kajang, Selangor, Malaysia

Patients applied

0 patients applied

Trial Officials

Wan Ying Gan, PhD

Principal Investigator

Universiti Putra Malaysia

Tie Min Jiang

Principal Investigator

Guilin University of Technology

Li Jun Chen, PhD

Study Director

Beijing Sanyuan Foods Co Ltd

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials